Loading clinical trials...
Loading clinical trials...
FINGORHYMS - Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis
Conditions
Interventions
Gilenya®; Novartis Pharmaceuticals Corporation
Locations
1
Germany
University Medical Hospital Hamburg-Eppendorf
Hamburg, Germany
Start Date
June 1, 2013
Primary Completion Date
December 31, 2019
Completion Date
December 31, 2020
Last Updated
January 8, 2019
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions